A Single-Center, Open-Label, Phase II, Proof-of-Concept Study with Pasireotide LAR in patients with progressive medullary thyroid cancer (MTC): preliminary data Abstract #586

Abstract content not available

Don’t be disappointed – you can look forward to seeing the full abstract from 10 March 2020 onwards.

Further abstracts you may be interested in

No result